Skip to main content
search
All Posts By

Dawn

Membership NewsMembership News Archive

2024 Membership Renewals – Reminder

  Please find this as a polite reminder if you have not yet done so to complete your renewal forms as soon as possible! Deadline: Wednesday 31 January 2024 Both forms are important as we hold this data in our CRM and when stakeholders and members ask us for information to contact members, we are able identify the companies they…
Dawn
January 17, 2024
Membership NewsMembership News Archive

Springing into 2024

As we enter 2024, there is a real sense of momentum in the BIVDA office.  It feels much longer ago than last week I was wishing members a happy New Year. I’d like to start this newsletter by introducing two new BIVDA initiatives. Our Springboard programme launches on the 1st February.  This is a really exciting piece of work, led…
Dawn
January 10, 2024
HighlightsHighlights Archive

Media Monitoring

NHS England trials home testing for Chronic Kidney Disease. Tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes as part of a £30 million tech and AI innovation fund this winter. The Healthy.io early detection device will initially be sent to 30,000 patients who are considered…
Dawn
January 10, 2024
HighlightsHighlights Archive

MHRA Roadmap

A new MedTech roadmap published by the MHRA The MHRA have today published a roadmap towards the future regulatory framework for medical devices. This sets out their planned activities into 2025. The roadmap is intended to deliver greater international harmonisation, with more patient-centred, proportionate requirements for medical devices which are responsive to technological advances. Dr Laura Squire, the MHRA’s MedTech Regulatory Reform…
Dawn
January 10, 2024
HighlightsHighlights Archive

Springboard Launch

BIVDA are excited to announce our collaboration with Barclays Eagle Labs to deliver the Springboard Programme in 2024. The BIVDA Springboard Programme is intended to help our innovative new member companies grow and develop by collaborating and connecting with leading industry experts.  The programme is designed to facilitate the understanding of the IVD market in the UK and beyond by…
Dawn
January 10, 2024
Membership NewsMembership News Archive

NIHR invites applications for Real World Evidence Programme

The NIHR’s Invention for Innovation programme in collaboration with the Office for Life Sciences & NICE will soon be inviting applications for our i4i & OLS Real World Evidence Programme. The call aims to support consortia to address real world evidence gaps to accelerate widespread adoption of technologies recommended for early use in the NHS through NICE Early Value Assessment (EVA). The…
Dawn
January 10, 2024
Membership NewsMembership News Archive

NHS and DHSC Launch Home Blood Testing Market Engagement.

DHSC have launched an engagement exercise to allow potential bidders for a blood self-sampling service to view and comment on the NHS requirements.  This is intended to sight DHSC on existing services which can supply, distribute, receive, analyse, and send results from self-testing cholesterol and blood glucose kits.  If suitable providers are identified, they may be given the opportunity to…
Dawn
January 10, 2024
Membership NewsMembership News Archive

DHSC Modern Slavery Review

DHSC have published their review into modern slavery and human trafficking within the NHS supply chain. The comprehensive review, covering nearly 1400 suppliers and 600,000 products, concluded that there are areas of high risk within the supply chain – predominately for PPE, surgical instruments, and cotton-based products. In a series of recommendations, DHSC suggest that due diligence forms part of…
Dawn
January 10, 2024
HighlightsHighlights Archive

Media Monitoring

The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis (The Lancet) This study reveals a high level of AMR burden for several bacterial pathogens and pathogen–drug combinations in the WHO African region. The high mortality rates associated with these pathogens demonstrate an urgent need to address the burden of AMR in Africa.…
Dawn
January 3, 2024
HighlightsHighlights Archive

New monthly MHRA newsletter

The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and blood components for transfusion in the UK. Subscribe to their new monthly newsletter to stay updated on their activities.
Dawn
January 3, 2024
Close Menu